Sanofi (SNY) Unit Receives FDA Approval for Menactra as Meningococcal Disease Booster Vaccination
Tweet Send to a Friend
Sanofi Pasteur, the vaccines division of Sanofi (NYSE: SNY), announced that the U.S. Food and Drug Administration (FDA) approved use ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
